Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

M. J. Fine, M. A. Smith, C. A. Carson, S. S. Mutha, S. S. Sankey, L. A. Weissfeld and W. N. Kapoor
Department of Medicine, University of Pittsburgh, Pa., USA.

OBJECTIVE--To systematically review the medical literature on the prognosis and outcomes of patients with community-acquired pneumonia (CAP). DATA SOURCES--A MEDLINE literature search of English-language articles involving human subjects and manual reviews of article bibliographies were used to identify studies of prognosis in CAP. STUDY SELECTION--Review of 4573 citations revealed 122 articles (127 unique study cohorts) that reported medical outcomes in adults with CAP. DATA EXTRACTION--Qualitative assessments of studies' patient populations, designs, and patient outcomes were performed. Summary univariate odds ratios (ORs) and rate differences (RDs) and their associated 95% confidence intervals (CIs) were computed to estimate a summary effect size for the association of prognostic factors and mortality. DATA SYNTHESIS--The overall mortality for the 33,148 patients in all 127 study cohorts was 13.7%, ranging from 5.1% for the 2097 hospitalized and ambulatory patients (in six study cohorts) to 36.5% for the 788 intensive care unit patients (in 13 cohorts). Mortality varied by pneumonia etiology, ranging from less than 2% to greater than 30%. Eleven prognostic factors were significantly associated with mortality using both summary ORs and RDs: male sex (OR = 1.3; 95% CI, 1.2 to 1.4), pleuritic chest pain (OR = 0.5; 95% CI, 0.3 to 0.8), hypothermia (OR = 5.0; 95% CI, 2.4 to 10.4), systolic hypotension (OR = 4.8; 95% CI, 2.8 to 8.3), tachypnea (OR = 2.9; 95% CI, 1.7 to 4.9), diabetes mellitus (OR = 1.3; 95% CI, 1.1 to 1.5), neoplastic disease (OR = 2.8; 95% CI, 2.4 to 3.1), neurologic disease (OR = 4.6; 95% CI, 2.3 to 8.9), bacteremia (OR = 2.8; 95% CI, 2.3 to 3.6), leukopenia (OR = 2.5, 95% CI, 1.6 to 3.7), and multilobar radiographic pulmonary infiltrate (OR = 3.1; 95% CI, 1.9 to 5.1). Assessments of other clinically relevant medical outcomes such as morbid complications (41 cohorts), symptoms resolution (seven cohorts), return to work or usual activities (five cohorts), or functional status (one cohort) were infrequently performed. CONCLUSIONS--Mortality for patients hospitalized with CAP was high and was associated with characteristics of the study cohort, pneumonia etiology, and a variety of prognostic factors. Generalization of these findings to all patients with CAP should be made with caution because of insufficient published information on medical outcomes other than mortality in ambulatory patients.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early mortality in patients with community-acquired pneumonia: causes and risk factors
Garcia-Vidal et al.
Eur Respir J 2008;32:733-739.
ABSTRACT | FULL TEXT  

Effects of Ageing and Gender on Naturally Acquired Antibodies to Pneumococcal Capsular Polysaccharides and Virulence-Associated Proteins
Simell et al.
CVI 2008;15:1391-1397.
ABSTRACT | FULL TEXT  

Incidence and predictive factors of lower respiratory tract infections among the very elderly in the general population. The Leiden 85-plus Study
Sliedrecht et al.
Thorax 2008;63:817-822.
ABSTRACT | FULL TEXT  

Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia
Chalmers et al.
Thorax 2008;63:698-702.
ABSTRACT | FULL TEXT  

The Lineage-c-Kit+Sca-1+ Cell Response to Escherichia coli Bacteremia in Balb/c Mice
Zhang et al.
Stem Cells 2008;26:1778-1786.
ABSTRACT | FULL TEXT  

Cross-Sectional and Prospective Study of Lung Function in Adults With Type 2 Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Yeh et al.
Diabetes Care 2008;31:741-746.
ABSTRACT | FULL TEXT  

A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU
Restrepo et al.
Chest 2008;133:610-617.
ABSTRACT | FULL TEXT  

Antibiotic Timing and Errors in Diagnosing Pneumonia
Welker et al.
Arch Intern Med 2008;168:351-356.
ABSTRACT | FULL TEXT  

Growth of Streptococcus pneumoniae on Human Glycoconjugates Is Dependent upon the Sequential Activity of Bacterial Exoglycosidases
Burnaugh et al.
J. Bacteriol. 2008;190:221-230.
ABSTRACT | FULL TEXT  

Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Risk and Outcome of Pneumonia
van de Garde et al.
Chest 2008;133:220-225.
ABSTRACT | FULL TEXT  

Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database
Petersen et al.
BMJ 2007;335:982-982.
ABSTRACT | FULL TEXT  

Effects of systemic steroids in patients with severe community-acquired pneumonia
Garcia-Vidal et al.
Eur Respir J 2007;30:951-956.
ABSTRACT | FULL TEXT  

Type 2 Diabetes and Pneumonia Outcomes: A population-based cohort study
Kornum et al.
Diabetes Care 2007;30:2251-2257.
ABSTRACT | FULL TEXT  

Pneumonia Severity Index Class V Patients With Community-Acquired Pneumonia: Characteristics, Outcomes, and Value of Severity Scores
Valencia et al.
Chest 2007;132:515-522.
ABSTRACT | FULL TEXT  

Increased Hospital Morbidity Among Trauma Patients With Diabetes Mellitus Compared With Age- and Injury Severity Score-Matched Control Subjects
Ahmad et al.
Arch Surg 2007;142:613-618.
ABSTRACT | FULL TEXT  

Etiology of Community-Acquired Pneumonia in Hospitalized Patients in Chile: The Increasing Prevalence of Respiratory Viruses Among Classic Pathogens
Diaz et al.
Chest 2007;131:779-787.
ABSTRACT | FULL TEXT  

Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic
Lim
Thorax 2007;62:1-46.
FULL TEXT  

Statin treatment and reduced risk of pneumonia in patients with diabetes
van de Garde et al.
Thorax 2006;61:957-961.
ABSTRACT | FULL TEXT  

Assessment of Analysis of Urinary Pneumococcal Antigen by Immunochromatography for Etiologic Diagnosis of Community-Acquired Pneumonia in Adults
Briones et al.
CVI 2006;13:1092-1097.
ABSTRACT | FULL TEXT  

Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Spindler and Ortqvist
Eur Respir J 2006;28:816-823.
ABSTRACT | FULL TEXT  

Resource Utilization of Adults Admitted to a Large Urban Hospital With Community-Acquired Pneumonia Caused by Streptococcus pneumoniae.
Sun et al.
Chest 2006;130:807-814.
ABSTRACT | FULL TEXT  

COPD is associated with increased mortality in patients with community-acquired pneumonia
Restrepo et al.
Eur Respir J 2006;28:346-351.
ABSTRACT | FULL TEXT  

Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia.
Waterer et al.
Chest 2006;130:11-15.
ABSTRACT | FULL TEXT  

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial
Christ-Crain et al.
Am. J. Respir. Crit. Care Med. 2006;174:84-93.
ABSTRACT | FULL TEXT  

Sleep in Critically Ill Chemically Paralyzed Patients Requiring Mechanical Ventilation
Hardin et al.
Chest 2006;129:1468-1477.
ABSTRACT | FULL TEXT  

Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population
van de Garde et al.
Eur Respir J 2006;27:1217-1222.
ABSTRACT | FULL TEXT  

Impact of Alcohol Abuse in the Etiology and Severity of Community-Acquired Pneumonia
de Roux et al.
Chest 2006;129:1219-1225.
ABSTRACT | FULL TEXT  

Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae
Siquier et al.
J Antimicrob Chemother 2006;57:536-545.
ABSTRACT | FULL TEXT  

Parapneumonic effusions and empyema.
Light
Proc Am Thorac Soc 2006;3:75-80.
ABSTRACT | FULL TEXT  

Epidemiology and Outcomes of Health-care-Associated Pneumonia: Results From a Large US Database of Culture-Positive Pneumonia
Kollef et al.
Chest 2005;128:3854-3862.
ABSTRACT | FULL TEXT  

Clinical and Radiographic Evidence of Pneumonia
WILKINS and WILKINS
radtech 2005;77:106-110.
ABSTRACT | FULL TEXT  

Empirical Atypical Coverage for Inpatients With Community-Acquired Pneumonia: Systematic Review of Randomized Controlled Trials
Shefet et al.
Arch Intern Med 2005;165:1992-2000.
ABSTRACT | FULL TEXT  

Does Guideline Adherence for Empiric Antibiotic Therapy Reduce Mortality in Community-acquired Pneumonia?
Aujesky and Fine
Am. J. Respir. Crit. Care Med. 2005;172:655-656.
FULL TEXT  

Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors
Schouten et al.
J Antimicrob Chemother 2005;56:575-582.
ABSTRACT | FULL TEXT  

The Controversy of Combination vs Monotherapy in the Treatment of Hospitalized Community-Acquired Pneumonia
Weiss and Tillotson
Chest 2005;128:940-946.
ABSTRACT | FULL TEXT  

Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study
van der Eerden et al.
Thorax 2005;60:672-678.
ABSTRACT | FULL TEXT  

Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care
Hak et al.
Fam Pract 2005;22:375-380.
ABSTRACT | FULL TEXT  

Quantitative PCR Assay Using Sputum Samples for Rapid Diagnosis of Pneumococcal Pneumonia in Adult Emergency Department Patients
Yang et al.
J. Clin. Microbiol. 2005;43:3221-3226.
ABSTRACT | FULL TEXT  

U.K. Controlled Trial of Intrapleural Streptokinase for Pleural Infection
Maskell et al.
NEJM 2005;352:865-874.
ABSTRACT | FULL TEXT  

Outpatient Care Compared with Hospitalization for Community-Acquired Pneumonia: A Randomized Trial in Low-Risk Patients
Carratala et al.
ANN INTERN MED 2005;142:165-172.
ABSTRACT | FULL TEXT  

Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Paganin et al.
Eur Respir J 2004;24:779-785.
ABSTRACT | FULL TEXT  

Identifying failure of empirical treatment for pneumonia: vigilance and common sense
Lim
Thorax 2004;59:918-919.
FULL TEXT  

Severe Acute Respiratory Syndrome: Correlation between Clinical Outcome and Radiologic Features
Hui et al.
Radiology 2004;233:579-585.
ABSTRACT | FULL TEXT  

Risk of Community-Acquired Pneumonia and Use of Gastric Acid-Suppressive Drugs
Laheij et al.
JAMA 2004;292:1955-1960.
ABSTRACT | FULL TEXT  

Cost-effectiveness of full-course oral levofloxacin in severe community-acquired pneumonia
Wasserfallen et al.
Eur Respir J 2004;24:644-648.
ABSTRACT | FULL TEXT  

Double-Blind, Randomized Study of the Efficacy and Safety of Oral Pharmacokinetically Enhanced Amoxicillin-Clavulanate (2,000/125 Milligrams) versus Those of Amoxicillin-Clavulanate (875/125 Milligrams), Both Given Twice Daily for 7 Days, in Treatment of Bacterial Community-Acquired Pneumonia in Adults
File et al.
Antimicrob. Agents Chemother. 2004;48:3323-3331.
ABSTRACT | FULL TEXT  

Increased Bacterial Resistance: PROTEKT US--An Update
Rybak
The Annals of Pharmacotherapy 2004;38:S8-S13.
ABSTRACT | FULL TEXT  

Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia
Tellier et al.
J Antimicrob Chemother 2004;54:515-523.
ABSTRACT | FULL TEXT  

Guidelines for Empiric Antimicrobial Prescribing in Community-Acquired Pneumonia
File et al.
Chest 2004;125:1888-1901.
ABSTRACT | FULL TEXT  

Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia
Roson et al.
Arch Intern Med 2004;164:502-508.
ABSTRACT | FULL TEXT  

Pulmonary Disease: Pneumonia, Chronic Obstructive Pulmonary Disease, Asthma, and Thromboembolic Disease
De Palo
J. Am. Podiatr. Med. Assoc. 2004;94:157-167.
ABSTRACT | FULL TEXT  

Glycemic Exposure Is Associated With Reduced Pulmonary Function in Type 2 Diabetes: The Fremantle Diabetes Study
Davis et al.
Diabetes Care 2004;27:752-757.
ABSTRACT | FULL TEXT  

Single-Dose Azithromycin for Respiratory Tract Infections
Law and Amsden
The Annals of Pharmacotherapy 2004;38:433-439.
ABSTRACT | FULL TEXT  

Tissue kinetics of telithromycin, the first ketolide antibacterial
Muller-Serieys et al.
J Antimicrob Chemother 2004;53:149-157.
ABSTRACT | FULL TEXT  

Blood Cultures for Community-Acquired Pneumonia: Piecing Together a Mosaic for Doing Less
Craven
Am. J. Respir. Crit. Care Med. 2004;169:327-328.
FULL TEXT  

Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults
Garau et al.
J Antimicrob Chemother 2003;52:826-836.
ABSTRACT | FULL TEXT  

Linezolid vs Vancomycin: Analysis of Two Double-Blind Studies of Patients With Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
Wunderink et al.
Chest 2003;124:1789-1797.
ABSTRACT | FULL TEXT  

Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)
Chan et al.
Thorax 2003;58:686-689.
ABSTRACT | FULL TEXT  

Mortality during hospitalisation for pneumonia in Alberta, Canada, is associated with physician volume
Marrie et al.
Eur Respir J 2003;22:148-155.
ABSTRACT | FULL TEXT  

Mycoplasma Disease and Acute Chest Syndrome in Sickle Cell Disease
Neumayr et al.
Pediatrics 2003;112:87-95.
ABSTRACT | FULL TEXT  

Case 14-2003 - A 73-Year-Old Woman with Pneumonia and Progressive Respiratory Failure
Waxman et al.
NEJM 2003;348:1902-1912.
FULL TEXT  

Chlamydia species as a cause of community-acquired pneumonia in Canada
Marrie et al.
Eur Respir J 2003;21:779-784.
ABSTRACT | FULL TEXT  

Impact of Initial Antibiotic Choice on Clinical Outcomes in Community-Acquired Pneumonia: Analysis of a Hospital Claims-Made Database
Brown et al.
Chest 2003;123:1503-1511.
ABSTRACT | FULL TEXT  

Impact of antimicrobial resistance on health outcomes in the out-patient treatment of adult community-acquired pneumonia: a probability model
Singer et al.
J Antimicrob Chemother 2003;51:1269-1282.
ABSTRACT | FULL TEXT  

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
Lim et al.
Thorax 2003;58:377-382.
ABSTRACT | FULL TEXT  

Editorial III: Hyperglycaemia and the lung
Philips and Baker
Br J Anaesth 2003;90:430-433.
FULL TEXT  

Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin
Fogarty et al.
J Antimicrob Chemother 2003;51:947-955.
ABSTRACT | FULL TEXT  

Pneumonia: Still the Old Man's Friend?
Kaplan et al.
Arch Intern Med 2003;163:317-323.
ABSTRACT | FULL TEXT  

Community-acquired pneumonia in the elderly: Spanish multicentre study
Zalacain et al.
Eur Respir J 2003;21:294-302.
ABSTRACT | FULL TEXT  

Testing Strategies in the Initial Management of Patients with Community-Acquired Pneumonia
Metlay and Fine
ANN INTERN MED 2003;138:109-118.
ABSTRACT | FULL TEXT  

Evaluation of a PCR Assay for Detection of Streptococcus pneumoniae in Respiratory and Nonrespiratory Samples from Adults with Community-Acquired Pneumonia
Murdoch et al.
J. Clin. Microbiol. 2003;41:63-66.
ABSTRACT | FULL TEXT  

Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia
Torres et al.
Eur Respir J 2003;21:135-143.
ABSTRACT | FULL TEXT  

Detection and Treatment of Bloodstream Infection: Laboratory Reporting and Antimicrobial Management
Munson et al.
J. Clin. Microbiol. 2003;41:495-497.
ABSTRACT | FULL TEXT  

Microbiological Testing and Outcome of Patients With Severe Community-Acquired Pneumonia
Rello et al.
Chest 2003;123:174-180.
ABSTRACT | FULL TEXT  

Management of Community-Acquired Pneumonia
Halm and Teirstein
NEJM 2002;347:2039-2045.
FULL TEXT  

Effect of Mechanical Ventilator Weaning Protocols on Respiratory Outcomes in Infants and Children: A Randomized Controlled Trial
Randolph et al.
JAMA 2002;288:2561-2568.
ABSTRACT | FULL TEXT  

Causes of Death for Patients With Community-Acquired Pneumonia
Stralin et al.
Arch Intern Med 2002;162:2491-2493.
FULL TEXT  

An Intervention To Improve Antibiotic Delivery and Sputum Procurement in Patients Hospitalized With Community-Acquired Pneumonia*
Lawrence et al.
Chest 2002;122:913-919.
ABSTRACT | FULL TEXT  

Withholding Antibiotic Treatment in Pneumonia Patients With Dementia: A Quantitative Observational Study
van der Steen et al.
Arch Intern Med 2002;162:1753-1760.
ABSTRACT | FULL TEXT  

Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections
Klugman
Eur Respir J 2002;20:3S-8s.
ABSTRACT | FULL TEXT  

Treatment of community-acquired lower respiratory tract infections in adults
Ortqvist
Eur Respir J 2002;20:40S-53s.
ABSTRACT | FULL TEXT  

Causes of Death for Patients With Community-Acquired Pneumonia: Results From the Pneumonia Patient Outcomes Research Team Cohort Study
Mortensen et al.
Arch Intern Med 2002;162:1059-1064.
ABSTRACT | FULL TEXT  

The pulmonary physician in critical care 3: Critical care management of community acquired pneumonia
Baudouin
Thorax 2002;57:267-271.
ABSTRACT | FULL TEXT  

Severity Assessment of Lower Respiratory Tract Infection in Elderly Patients in Primary Care
Seppa et al.
Arch Intern Med 2001;161:2709-2713.
ABSTRACT | FULL TEXT  

BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
Thorax 2001;56:iv1-64.
FULL TEXT  

Bronchopulmonary Disposition of the Ketolide Telithromycin (HMR 3647)
Muller-Serieys et al.
Antimicrob. Agents Chemother. 2001;45:3104-3108.
ABSTRACT | FULL TEXT  

Quality Indicators for the Management of Pneumonia in Vulnerable Elders
Rhew
ANN INTERN MED 2001;135:736-743.
FULL TEXT  

Evaluation of a Rapid Immunochromatographic Test for Detection of Streptococcus pneumoniae Antigen in Urine Samples from Adults with Community-Acquired Pneumonia
Murdoch et al.
J. Clin. Microbiol. 2001;39:3495-3498.
ABSTRACT | FULL TEXT  

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin
File et al.
J Antimicrob Chemother 2001;48:67-74.
ABSTRACT | FULL TEXT  

Initial risk class and length of hospital stay in community-acquired pneumonia
Menendez et al.
Eur Respir J 2001;18:151-156.
ABSTRACT | FULL TEXT  

Clinical Evaluation of the Management of Community-Acquired Pneumonia by General Practitioners in France
Fantin et al.
Chest 2001;120:185-192.
ABSTRACT | FULL TEXT  

Diabetes and the Risk of Infection-Related Mortality in the U.S.
Bertoni et al.
Diabetes Care 2001;24:1044-1049.
ABSTRACT | FULL TEXT  

Early Switch From Intravenous to Oral Antibiotics in Hospitalized Patients With Bacteremic Community-Acquired Streptococcus pneumoniae Pneumonia
Ramirez and Bordon
Arch Intern Med 2001;161:848-850.
ABSTRACT | FULL TEXT  

Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged >=75 yrs
Lim and Macfarlane
Eur Respir J 2001;17:200-205.
ABSTRACT | FULL TEXT  

Appropriate Microbiological Testing in Community-Acquired Pneumonia
Wunderink and Waterer
Chest 2001;119:5-7.
FULL TEXT  

Clinical Efficacy of Intravenous followed by Oral Azithromycin Monotherapy in Hospitalized Patients with Community-Acquired Pneumonia
Plouffe et al.
Antimicrob. Agents Chemother. 2000;44:1796-1802.
ABSTRACT | FULL TEXT  

Implementation of Admission Decision Support for Community-Acquired Pneumonia
Dean et al.
Chest 2000;117:1368-1377.
ABSTRACT | FULL TEXT  

Decisions to treat or not to treat pneumonia in demented psychogeriatric nursing home patients: development of a guideline
van der Steen et al.
J. Med. Ethics 2000;26:114-120.
ABSTRACT | FULL TEXT